Compounds > quipazine
Page last updated: 2024-08-16

quipazine and olanzapine

quipazine has been researched along with olanzapine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R1
Fuller, RW; Snoddy, HD1
Fowler, SC; Stanford, JA1
Benvenga, MJ; Bymaster, FP; Calligaro, DO; Cohen, IR; Falcone, JF; Hemrick-Luecke, SK; Martin, FM; Moore, NA; Nelson, DL; Nisenbaum, LK; Rasmussen, K; Schaus, JM; Sundquist, SJ; Tupper, DE; Wiernicki, TR1

Other Studies

4 other study(ies) available for quipazine and olanzapine

ArticleYear
Physical binding pocket induction for affinity prediction.
    Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19

    Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A

2009
Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate.
    Research communications in chemical pathology and pharmacology, 1992, Volume: 77, Issue:1

    Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Corticosterone; Dopamine Antagonists; Drug Evaluation, Preclinical; Male; Neurosecretory Systems; Olanzapine; Pergolide; Pirenzepine; Quipazine; Rats; Rats, Inbred Strains; Serotonin Antagonists

1992
Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness.
    Psychopharmacology, 1997, Volume: 132, Issue:4

    Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Tolerance; Forelimb; Male; Muscarinic Antagonists; Olanzapine; Pirenzepine; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Substance Withdrawal Syndrome; Tremor; Trihexyphenidyl

1997
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Catalepsy; Cocaine; Corticosterone; Drug Evaluation, Preclinical; Electrochemistry; Electrophysiology; Fasting; Female; Immunohistochemistry; Male; Molecular Structure; Motor Activity; Nucleus Accumbens; Olanzapine; Piperazines; Prolactin; Quipazine; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Histamine H1; Serotonin Receptor Agonists; Thiophenes; Time Factors

2005